Source:http://linkedlifedata.com/resource/pubmed/id/16515599
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2006-3-6
|
pubmed:abstractText |
The purpose of this study was to evaluate cyclooxygenase-2 (COX-2) expression in epithelial ovarian tumors and its correlation with vascular endothelial growth factor (VEGF) and p53 expression. Immunohistochemical studies with anti-COX-2, anti-VEGF, and anti-p53 antibodies were carried out in 54 malignant and 23 borderline epithelial ovarian tumors. Elevated COX-2 expression was detected in 77.8% of ovarian carcinomas, which was significantly higher than that of borderline tumors (26.1%) (P < 0.001). In ovarian carcinomas, there was no significant correlation between COX-2 expression and other clinicopathologic features. Elevated VEGF expression was detected in 74.1% of ovarian carcinomas, and p53 expression was found in 64.8% of ovarian carcinomas. COX-2 expression was statistically correlated with elevated VEGF expression (P < 0.001) and p53 positivity (P < 0.05). On a univariate analysis, FIGO stage (P < 0.0001), histologic type (P= 0.0104), and COX-2 expression (P= 0.0135) were significant prognostic factors for overall survival. In a multivariate analysis, FIGO stage (P < 0.0001) was the only independent prognostic factor for poor survival. These findings suggest that COX-2 may play a role in the progression of epithelial ovarian tumors and that COX-2 expression may contribute to ovarian tumor angiogenesis by stimulating VEGF expression. p53 may be responsible for the regulation of COX-2 expression.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1048-891X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
247-53
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16515599-Adenocarcinoma,
pubmed-meshheading:16515599-Adult,
pubmed-meshheading:16515599-Aged,
pubmed-meshheading:16515599-Aged, 80 and over,
pubmed-meshheading:16515599-Cyclooxygenase 2,
pubmed-meshheading:16515599-Female,
pubmed-meshheading:16515599-Humans,
pubmed-meshheading:16515599-Middle Aged,
pubmed-meshheading:16515599-Neoplasm Staging,
pubmed-meshheading:16515599-Ovarian Neoplasms,
pubmed-meshheading:16515599-Survival Analysis,
pubmed-meshheading:16515599-Tumor Suppressor Protein p53,
pubmed-meshheading:16515599-Vascular Endothelial Growth Factor A
|
pubmed:articleTitle |
Expression of cyclooxygenase-2 in epithelial ovarian tumors and its relation to vascular endothelial growth factor and p53 expression.
|
pubmed:affiliation |
Department of Pathology, Chonnam National University Medical School and Research Institute of Medical Science, Gwangju, Korea. jshinlee@hanmail.net
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|